Coexistence of metabolic syndrome (MS) and atrial fibrillation (AF) is common. Studies suggest that different components of MS, including hypertension, diabetes, dyslipidemia, and obesity, increase the likelihood of AF.
In patients with metabolic syndrome, both all-cause and cardiovascular disease mortality appear to be substantially lowered in those with optimal 25-hydroxyvitamin D (25[OH]D) levels when compared with those with suboptimal levels, according to a study from European researchers. Future investigations should assess the role of vitamin D supplementation in optimizing 25(OH)D levels to reduce mortality in these individuals.…
A scientific statement from the American Heart Association discusses challenges and issues associated with assessing adiposity. Recommendations are provided for identifying at-risk overweight and obese patients.
In an attempt to streamline the definition of metabolic syndrome, several professional organizations have released a joint statement that identifies specific criteria for the clinical diagnosis of the condition.